Patent 7553500 was granted and assigned to Pfizer Limited on June, 2009 by the United States Patent and Trademark Office.
Pharmaceutical compositions having uniform drug distribution and potency utilizing laxofoxifene as an active ingredient and containing a silicon dioxide to reduce loss of the active ingredient during the manufacturing process and methods for manufacturing such compositions are disclosed.